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THE study of the mammary cancer forms a most advantageous start'mg-poi'nt
for the investigation of the hereditary factor,% in cancers, because it is moreeasily
recognized and more accurately diagnosed than malignant growths at most
other sites. Moreover it produces, in the great majority of patients, a clearly
defined rango of pathological conditions, which include spheroidal-celled carci-
noma, Paget's disease of the nipple, adeno-careinoma, and the typical scirrhous
condition in long-standing cases.
I
The history of investigations into the genetic. aspect has been summarized
by Japobsen (1946). Some important records of pedigrees, showing apparent.
transmission from mother to daughter, were published nearly a century ago.
The most remarkable was recorded by Broca (1866), in which four generations
of females had the disease.
In spite of evidence brought forward by a great many observers that mam-
mary cancer can frequently be found affecting several of the female members
of afamily group, doubt,still remains as to whetherheredityplays anysignificant'
aetiological part. This doubt arises because of the great prevalence of the
disease in the general population, where it is responsible for nearly 3 per cent of
all female deaths. With so comm'on a condition, it is difficult to demonstrate
convincingly that the occas'lonal familial conoentration is not merely the result
of a random distribution of cases.
To obviate this uncertainty, most investigators in recent years have collected
a series of cases, noted the incidence of similar disease among their relatives, and
compared it with the corresponding incidence among a control group of cases
free from the disease, selected so far as possible at random. In spite ofelaborate
precautions,-the difficulties, involved in obtaining a satigfactory control group of family histories to match those of the propositae, have repeatedly proved
almost insuperable. The result is that many workers (Hanhart, 1943 ; Passey,
1942) still 'consider that there is, insufficient evidence to prove the reality of
familial transmission of mammary cancer or of aAy type of human ma"lignant disease. Stocks and Karn (1933) found no evidence that a history of cancer in
relatives increased the risk of cancer to any- measurable extent.
Several extensive surveys have beenpublished, allofwhichgive some evidence
for believing that mammary cancer is unusually prevalent amon the mothers
and sisters of affected cases. Among the important recent investigations are
those of Lane-Claypon (1926) on 508 propositae, Wainwright (1931) on 784,
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investigations, however, some uncertAinty remains as to whether the incidence
of cancer cases, ascertained in the control populations, is correct. The carefully
chosen control group examined by Jacobsen contained indeed far fewer cases
than would be expected to occur on the hypothesis that the mortality within the
grou is the same as that of the general population. The result of these doubts
is to reduce considerably the force of demonstrations which might otherwise
seem very convincing.
The Present Investigation.
The survey now described was undertaken with two main objectives. In
the first place it was hoped that a direct comparison of deaths from different
types of cancer in the relatives of a series of propositae could be compared directly with the rates given in statistics ofthe generalpopulation. This should
remove some of the uncertainties inherent in collecting a control group for com-
parison, and make possible fairly accurate inferences about the existence or
otherwise of familial con'centration of cases. Secondly, the material was com-
piled in such a way that, ifthe result should show definite evidence for the heredi-
tary transmiss'lon of mammary cancer, indications of the type of inheritance
could also be obtained. In particular, the possibilities of transmission through maternal milk or the cytoplasm were considered as possible hypotheses. In-
heritance of a factorcausingspecialpredisposition ofcertain sites in some families
but not in others was kept in mind also as a possibility. The material, which was collected, started in each instance with a patient attending a clinic after the diagnosis of mammary cancer had been made by a
competent surgeon or pathologist and, often, by both. The patients were
attending either University College ilospital or the London Hospital, and they
were personally interviewed. All possible hospital records and reports were
searched or checked by correspondence. This procedure applied b6th to the
propositae and to any of their relatives who were reported to have suffered from
malignant disease. Unfortunately, in a number 'of instances, records had been
destroyed by enemy action during the war. Ideally, the death certifica'te of
every relative believed to have died of malignant disease should have been
obtained, as corroborative evidence, but th'is we have not been able to do. The
routine investigation of family histories was confined to each patient's parents, brothers and sisters, children, grandparents, uncles and aunts. These data, it is
hoped, may prove to be more valuable than those previously collected in that, with careful questioning, the year ofdeath as well as the age was obtained. This'
information was -complete for the mothers who had died, less so for the sibs
and fathers.
Altogether 521 histories of cases of mammary cancer were colle'cted. In
nine ofthese thediagnosis was considered to be unreliable andthey wererejected. There were, also, two male casesandthese were setaside ; inneither wasanything .of note found in the family history. The 510 remaining cases were analysed from a number of different points of view.
Analy8i8ofthe8ample.
The mean age at onset of the disease in the 510 cases was 51-7 years', with a
standard deviation of 11-4 years. The distribution is set out in Table 1.170 L. S. PENROSE, H. J. MACKENZIE AND M. N. KARN
TABLE I.-Age of Onset of Disease in Propositae.
Number with at
Age. Total number. least one affected
relative.
20- 1
25- 5 2
30- 21 4
35- 43 11
40- 70 13
45- 101 25
50- 72 19
55- 59 14
60- 64 15
65- 38 11
70- 25 1
75- 9 1
80- 2
85-
All ages 510 116
Mean (years) 51- 7 51-0
Standard deviation (years) 11-4 10-4
In thepedigrees of 116 instances one or more relatives with mammary cancer
were ascertained. The distribution of these 116
" familial
" cases and the mean
age of onset of their illness (51
-0 years) was extremely similar to that of the
remaining
" non-familial
" cases. This finding does not support Jacobsen's
assertion that familial cases have an earlier onset than others. Among the
group of 510 women, 408 were married but 91 of these had no children. The
infertility ratio, 91 out of408, or 22-3 per cent, significantly exceeds the value of
17-3 per cent for married women of the same mean age given by the Registrar-
General (1938), and supports the view that nulliparity is an etiological factor.
The mean age of the patients when first interviewed for purposes of this
survey was 55-2 years. This indicates that they had, on the average, lived
three-and-a-halfyears since firstgigns ofthe disease hadappeared. Undoubtedly
the survival ofthe patient was a property, which determined her inclusion in the
investigation, and the longer the survival, the more probably would she be
selected as a proposita. On the whole, therefore, there has been a slight, un-
avoidabletendency to dealwith cases inwhom treatment has beencomparatively
successful. Conversely, many of them were still under radiological treatment,
and others were attending hospital on account of recurrence, so that some cases
may have beeninadverteii,.Iy selected on account ofundne severity ofsymptoms.
These cons'iderations must be kept in mind when interpreting the data, particu-
larly when considering the distribution of cases with respect to Age of onset.
Of the 510 propositae, 255 were affected first on the left side and 253 on the
right side ; in two instances there was uncertainty on thispoint.
Familial data: moaers.-The mothers of 408 patients were ascertained to
have died-a'nd, in the case of '25 of these women, death was due to mammary171 HUMAN MAMMARY CANCER
cancer. Other types of malignant disease accounted for the deaths of 51 of the
mothers ofpropositae. The date of death and the age at the time were recorded
for each case. In a few instances the dates were approximate, but could hardly
be more than a few years in error. The expected proportion of deaths due to
mammary cancer and other types of malignancy in each year and at each age
can be obtained on the basis of the general population statistics. An example
ofsuch results is shown in Table IT.
TABLE II.-Expected Proportion of Death8Due to Cancer.
Female8, England and Walm, 1925-29.
Other types of
malignancy.
0-0023
0-0115
0-0143
0-0243
0-0543
0-0903
0-1409
0- 1754
(1-1938
0- 1917
0- 1807
0- 1613
0- 1384
0-0979
0-0533
Age group.
0-9
10-19 .
20-24 .
25-29 .
30-34 .
35-39 .
40-44 .
45-49 .
50-54 .
55-59 .
60-64 .
65-69 .
70-74 .
75-79 .
80 and over
Mammary cancer.
0-0000
0.0000
0-0003
0-0037
0-0131
0 0-0298
.. 0-0526
0-0653
0-0632
0-0521
0-0408
0-0294
0-0216
0-0168
0-0122
All ages 0- 1243 0-0239
Thus the expected number ofdeaths from these two causes among the mothers
of the propositae could be calculated. The distribution of deaths by year and
age is shown in Table III.
From' this table the number of deaths due to mammary cancer if the women
had been subject to the mortality in the general population was estimated at
11-17, a figure significantly less than the observed 25. For other types of
malignancy the mortality among mothers of propositae showed no significant increase above expected total, i.e. 51 observed as compared with 48-76 expected. There were 102 mothers stillliving at the time ofinvestigation a'nd, ofthese, six were know-n to be under treatment for mammary cancer while four had some
other type ofmalignant disease. No correlation between ag'e of onset of breast
cancer in mothers and age of onset in patients could be demonstrated.
Familial data : 8i8ter8.-A similar survey of the patients' sisters revealed
that, out of a total of 1255 individuals, 365 had died, though the cause and
date were unknow-n for 58 of these. For theremaining 307 deaths the ages and
dates were classified as shown in Table IV. Calculating the expected number of
deaths due to mammary cancer, as with the mothers, led to -a value of 6-98.172 L. S. PENROSE) H. J. MACKENZIE AND M. N. KARN
TABL-E III.-Di8tribution of Deaths of Mothers of PrOP08itae by Age and Date.
Date.
Age. All (A.) (B.) dates.
20-24 I 1
25-29 1
30-34 5 2 1 2 1 1 12 I
35-39 1 3 2 '1 3 2 1 2 16
40-44 2 3 1 3 3 2 14 I 1
45-49 3 3 2 2 2 1 1 1 15 2
50-54 I 4 1 3 3 4 5 5 2 28 7 4
55-59 -1 1 1 3 3 3 3 5 2 2 2 26 4 3
60-64 1 2 6 12 3 1 9 4 10 6 54 11 7
65-69 2 5 5 4 10' 7 13 6 1 53 8 3
70-74 4 7 5 12 4 18 4 4 58 9 3
75-79 2 3 5 8 10 3 7 11 3 52 4
80-84 1 2 2 5 6 7 6 4 33 4
85-89 2 4 2 2 9 9 3 31 I
90-94 2 7 2 2 13 1
95-99 1 I
Allages. 2 10 9 11 16 22 38 37 33 61 39 67 46 17 408
(A) 1 1 2 5 7 2 7 5 17 3 - 51
(B) 1 - 3 2 4 1 4 1 3 4 1 2.)
(A) Due to types of malignancy other than mammary cancer.
(B) Due to mammary cancer.
TABLIF, W.-Di8tribution of Deaths of Sider8 of Propo8itae by Age and Date.
Date.
Age. -A- 'All (A.) (13. dates. '75-'80- '85--'90-'95-'00-'05--'10--'15-'20-'25-'30-'35-'40-'45-
Ldancy 17 21 14 15 8 14 10 2 1 1 103
10-14 2 1 1 1 3 3 11
15-19 I 2 1 2 2 8
20-24 4 2 1 4 2 1 14 I
25-29 2 2 2 3 10
30-34 1 2 3 1 4 1 4 4 2 22 2 -21
35-39 I 2 2 1 1 7 1
40-44 I 3 1 2 1 2 1 11 2 1
45-49 I 1 2 1 2 3 2 .. 12 2 3
50-54 2 7 3 2 7 3 24 3 5
55-59 I 7 4 5 1 18 2 4
60-64 4 5 8 7 24 5
65-69 4 3 5 8 20 I
70-74 2 5 5 3 15 1
75-79 1 5 6
80-84 2 2
Allages. 17 23 16 21 12 21 13 19 12 14 17 26 28 39 29 307
(A) I I 1 4 7 2 3 19
(B) 1 1 5 5 10 I 23
(A) Due to types of malignancy other than mammary cancer.
(B) Due to mammary cancer.
Actually 23 had died of this condition. Only 19 had died of other types of
malignant diseaseagainst anexpected number of 25-21. Again, there is a highly
significant increase in deaths from mammary cancer, even more marked than for
mothers, but nosigni-ficantd'ivergence from expectation inrespect ofdeaths from
other types ofmal'ignancy.173 HUMAN MAMMARY CANCER
Among the 890 sisters stillliving at the time ofinvestigation, 24 were known
to have been under treatment for breast cancer and seven for other types of
malignant disease. Again, the incidence of these conditions among the living
relatives echoes the general effect shown by analysis of causes of death.
Investigation of the age of onset in the 47 affected sisters in these families
in a single entry table showed a significant coiTelation, + 0-57, with age of onset
in propositae. It is uncertain how far this effect is real because patients,
coming under observation in the younger age-groups, are notlikely to have many
sisters old enough to have developed the disease in late life. Moreover, the
correlationofage of onset of other kinds ofmalignant disease in 26 sistersshowed
a similarlypositive value of 0-79. Hence any likeness of onset age ofmammary
cancer in sisters is not peculiar to this type ofmalignancy.
Another interesting correlation concerns the sites affected in pairs of sisters
and other relatives. Thelaterality ofinitial lesions showed a strong tendency to
similarity in sisters and the figures are set out in Table V. For mothers, there
TABLEV.-Laterality of Mammctry Cancer in Relatives.
Mothers. Sisters.
Propositae.
Right. Both. Left. Unknown. Total. Right. Both. Left. Unknowit. Total.
Right side 7 1 7 1 16 12 10 3 25
Left side 2 10 3 15 4 1 16 1 22
Total 9 1 17 4 31 16 1 26 4 47
was a similartendency, which by itselfwas not strongenough to excite attention.
However, the figures for mothers and sisters together are notable enough to
suggest that the tendency towards homolaterality in families is real.
Familial data: fathers and brothers.-As an additional check on the method
used for estimating the proportion of deaths attributable to malignant disease,
the data on fathers and brothers of the propositae were analysed in the same
way that data on mothers and sisters had been. Only one case ofmale mammary
cancer was found among these relatives but even this must be regarded as very
exceptional in so few families. The observed number of male deaths from other
types of cancer was not significantly different from expectation among either
fathers or brothers. The results are set out for compari'son with those based
upon the female relatives in Table VI.
Specific transmiMion.
The evidence from the mothers and sisters, fathers and brothers of the pro-
positae, as summarized in'Table VII, strongly suggests that transmission of a
specificfactor is amajor causeofmammary cancer. Thehypothesisofinheritance
of special organic disposition s'uggested by Bauer (1925) is supported by the
homolateralfamilialfindings. Thattheory, however,implies asignificantdecrease
in the incidence of malignancy of other types in these families, which was not
found in the present survey. Nor was there any increase in the incidence of
cancergenerally, which might have suggested a general hereditary predisposition
tomalignancy ofanytype.510 31 55
890 24 7
58 0 0
307 23 6-97 19 25-23
1255 47 26
73 0 1
17 0 0
420 0 0.10 41 52-32
510 0 43
780 0 2
64 0 0
455 1 0.05 29 28-14
1299 1 31
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TABLF, VI.-Incidence.of Cancer Ca,,w in Belativm of .510'Propo8itae.
Aammary cancer
cases.
u- A- ----N
Observed. Expected.
6
Other malignant
diseases.
t
A
Observed. Expected.
4
Number of
]persons
observed.
102
Relative.
Mother
Status.
. Living
Dead:
Cause unknown
Cause known .
0 0
408 25
0
11-17 51 48- 78
Total
Sifft-er Living
Dead:
Cause unknown
Cause known
Total
Father Living
Dead:
Cause unknown
Cause known
Total
Brother Living
Dead:
Cause unknown
Cause known
Total
TAiElLIF,VII.-Summary of Analy8i8 of Decea,8ed Relativm of 510 Propo8itae.
Number due to
mammary cancer.
6bserved. ^Expected.-
25 11- 17
23 6- 97
0 0-03
1 0-02
49 18- 19
1
v
52- 1
Number due to other
types ofmalignancy.
Observed. Expected.
51 48- 78
0 19 25-23
41 52- 32
29 28- 14
140 154-47
l--
i-2
Total number
of deaths.
... 408
307
420
455
0 1590
Relative.
Mother
Sister
Father
Brother
Totals
The famifialincidence among sibs is nothighenough to suggest any Mendehan
explanation of the inb .;ritance. The consanguinity test for rare recessive genes
gave negative results. Three propositae had first cousin parents, and two hadHUMAN MAMMARY CANCER 175
parents more distantly related. These findings are in close agreement with
figures found by Bell (1939) for all types of hospital patients.
In view ofthe work on mice by Bittner (1937), a factor derived from maternal
cytoplasm, transmitted by way of milk, colostron or cytoplasm of the ovum
might be a specific cause. If this were so, maternal relatives should be more
frequently affected with mammary cancer than the corresponding paternal
relatives. In the present series no calculation could usefully be attempted of
the expected incidence in such relatives of the propositae. However, among
maternal aunts there were 29 mammary against 21 other cases of malignant
disease, whereas among paternal aunts only 16 cases against 24 of other types
TABLE ,VIII.
Mammary. Other.
Malignant disease - - -
in relatives. Grand- tl A Grand- Ttl Aunts. mothers. Total. Aunts. mothers. Total.
Maternal line . . 28 9 37 . 21 23 44
Paternal line . . 17 2 19 . 24 6 30
were found. These figures, given in Table VIII, are suggestive though scarcely
conclusive evidence of maternal line inheritance. They derive some slight
support from the investigation of maternal and paternal grandparents, where a
relative excess of mammary cancer among maternal grandmothers was noted.
In these somewhat distant relatives the unreliability ofpaternal line informa-
tion causes difficulty of interpretation. In both the parental and grandparental
generations, however, sisters are more intensely affected than mothers, so far as
breast cancer is concerned, and this is a fact of some gerietical importance. In
Mendelian genetics it would be attributed to a recessive tendency on the part
of the causal gene, but it may be due to a constitutional effect associating
infertility with liability to the disease in question.
A search for evidence that mammary cancer can be inherited through
maternal milk gave negative results, although a more accurately planned
study with this point especially in mind might show a different picture.
SUMMALRY.
A series of 510 cases of mammary cancer in females was studied. Family
investigations showed that the same disease occurred with significantly increased
frequency in sisters and mothers ofthese propositae. The rate of malignancy of
other types in these relatives was not increased. A specific genetical agent,
responsible for the disease, is postulated, which may be inherited mainly through
the maternal line.
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